Publications Database

Brignell A. et al. (2018)

A systematic review and meta-analysis of the prognosis of language outcomes for individuals with autism spectrum disorder.

Autism and Developmental Language Impairments

3 pp. 1-19.

Read Abstract (New Window)

Carter M. et al. (2011)

Interventions used with an Australian sample of preschool children with autism spectrum disorders.

Research in Autism Spectrum Disorders

5(3), pp. 1033-1041

Read Abstract (New Window)

Dadds M. R. et al. (2014)

Nasal oxytocin for social deficits in childhood autism: A randomized controlled trial.

Journal of Autism and Developmental Disorders

44(3), pp. 521-531.

Read Abstract (New Window)

Hurwitz R. et al. (2012)

Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.

Cochrane Database of Systematic Reviews

Read Abstract (New Window) Read Full (New Window)

James S. et al. (2015)

Chelation for autism spectrum disorder (ASD) (Review).

Cochrane Database of Systematic Reviews

(5),

Read Abstract (New Window) Read Full (New Window)

James S. , Montgomery P. , Williams K. J. (2011)

Omega-3 fatty acids supplementation for autism spectrum disorders (ASD)

Cochrane Database of Systematic Reviews

Read Abstract (New Window) Read Full (New Window)

Roberts J. M. A. et al. (2011)

A randomised controlled trial of two early intervention programs for young children with autism: Centre-based with parent program and home-based.

Research in Autism Spectrum Disorders

5(4), pp. 1553-1566.

Read Abstract (New Window)

Samtani A. et al. (2011)

Diagnostic tests for autism spectrum disorders (ASD) in preschool children.

Cochrane Database of Systematic Reviews

(3), Art. No.: CD009044

Read Abstract (New Window)

Sinha Y. et al. (2004)

Auditory integration training and other sound therapies for autism spectrum disorders.

Cochrane Database of Systematic Reviews

(1),

Read Abstract (New Window) Read Full (New Window)

Sinha Y. , Silove N. , Williams K. J. (2006)

Chelation therapy and autism.

British Medical Journal

333(7571), p. 756

Read Full (New Window)

Williams K. J. et al. (2011)

Cochrane Review: Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).

Evidence-Based Child Health: A Cochrane Review Journal

6(4), pp. 1044-1078

Read Abstract (New Window)

Williams K. J. , Wray J. A. , Wheeler D. M. (2012)

Intravenous secretin for autism spectrum disorders (ASD).

Cochrane Database of Systematic Reviews

4 CD003495.

Read Abstract (New Window) Read Full (New Window)

Williams K. J. , Marraffa C. (2012)

No evidence yet to support omega-3 fatty acids as a treatment for autism.

Journal of Pediatric Health Care

48(6), pp. 534-536.

Read Abstract (New Window)

Williams K. J. et al. (2015)

Regression in autism spectrum disorders.

Journal of Paediatrics and Child Health

January, 51(1), pp. 61-64.

Read Abstract (New Window) Read Full (New Window)

Williams K. J. et al. (2013)

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).

Cochrane Database of Systematic Reviews

CD004677

Read Abstract (New Window) Read Full (New Window)

Williams K. J. , Hazell P. (2010)

Selective serotonin reuptake inhibitors for autism spectrum disorders.

Journal of Evidence Based Medicine

3(4), pp. 231

Williams K. J. et al. (2008)

The prevalence of autism in Australia: Can it be established from existing data?

Journal of Paediatrics and Child Health

44(9), pp. 504-510

Read Abstract (New Window)

Woolfenden S. et al. (2012)

A systematic review of two outcomes in autism spectrum disorder - epilepsy and mortality.

Developmental Medicine and Child Neurology

54(4), pp. 306-312.

Read Abstract (New Window)